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 Patient: Female, 73
 Final Diagnosis: Giant liver hemangioma
 Symptoms: Abdominal discomfort • abdominal enlargement • Icterus
 Medication: —
 Clinical Procedure: Enucleation after embolization of liver failure-causing giant liver 
 Specialty: Surgery
 Objective: Unusual clinical course
 Background: Hepatic hemangioma is a congenital tumor of the mesenchymal tissues of the liver. While typically benign, these 
tumors can occasionally grow to sufficient size to cause a number of symptoms, including pain, severe hepat-
ic dysfunction, or, rarely, consumptive coagulopathy. In such instances, surgical treatment may be warranted.
 Case Report: We present a case of a symptomatic giant hepatic hemangioma in an elderly patient who presented with im-
pending liver failure. She was successfully treated with a combination of surgical enucleation and liver resec-
tion after preoperative arterial embolization. We also provide a brief discussion of current treatment options 
for giant hepatic hemangiomas.
 Conclusions: Early referral to experienced surgical centers before the onset of dire complications such as severe hepatic dys-
function and liver failure is recommended.
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Background
Hepatic hemangioma is a congenital tumor of the mesenchy-
mal tissues of the liver. While typically benign, these tumors 
can occasionally grow to sufficient size to cause a number of 
symptoms, including pain, severe hepatic dysfunction, or, rare-
ly, a consumptive coagulopathy (Kasabach-Merritt syndrome). 
In such instances, surgical treatment may be warranted. While 
multiple surgical techniques are described in the literature, enu-
cleation is considered the safest and most effective approach. 
However, in the case of unusually large tumors, a multistage 
approach with a goal of pre-operative reduction in tumor size 
and vascularity with embolization may be advantageous. We 
present a case of a symptomatic giant hepatic hemangioma in 
an elderly patient that was successfully treated with combina-
tion of surgical enucleation and liver resection after preoper-
ative arterial embolization. We also provide a brief discussion 
of current treatment options for giant hepatic hemangiomas.
Case Report
The patient was a 73-year-old African American woman with 
history of atrial fibrillation, hypothyroidism, diabetes, and hy-
pertension. She had been diagnosed with a hepatic hemangi-
oma approximately 35 years ago when she underwent an ab-
dominal hysterectomy. She was managed conservatively and 
remained asymptomatic over the subsequent decades. She 
presented to our Emergency Department with recent onset 
of scleral icterus and increasing intensity of dull right upper-
quadrant pain. This was accompanied by 1 week of light-col-
ored stools and dark urine. Physical examination at presenta-
tion was significant for scleral icterus and a firm, distended, 
non-tender abdomen. The patient’s Karnofsky Performance 
Scale Index was 70%.
Laboratory evaluation revealed elevated liver enzymes (AST 
840 U/L, ALT 515 U/L), hyperbilirubinemia (total bilirubin 
14.5 md/dL, conjugated bilirubin 12.2 mg/dL), and coagulop-
athy (INR 3.1). Selected laboratory values are shown in Table 
1. Computerized tomography of the abdomen showed multiple 
Laboratory Value Reference range Admission POD #1 POD #3 At 4-months
Liver function tests
 Aspartate aminotransferase (unit/L) 0–50 521 320 104 35
 Alanine aminotransferase (unit/L) 0–50 344 171 81 25
 Alkaline phosphatase (unit/L) 0–120 132 77 49 115
 Bilirubin, total (mg/dL) 0–1.3 15.7 12.7 9 0.5
 Bilirubin, conjugated (mg/dL) 0.0–0.4 11.9 10.2 7.3 0.2
 Protein, total (g/dL) 6.4–8.5 7.2 5.6 5.4 7.6
 Albumin (g/dL) 3.7–5.2 3.2 2.9 3.2 4.2
Hematology
 White-cell count (109 cells/L) 3.9–11.7 3 3.5
7.1
4
 Hemoglobin (g/dL) 12–15 12 10.9 8.1 12.9
 Hematocrit (%) 34.8–45 36.4 31.3 22.9 39.1
 Platelets (109 cells/L) 172–440 149 157 92 171
Coagulation
 Prothrombin time (seconds) 12–14.6 17 17.2 16.1 13.3
 Activated prothrombin time (seconds) 25–36 – 33 37 –
 International normalized ratio 1 3.1 1.5 1.3 1
 Fibrinogen (mg/dL) 200–450 – 298 484 –
Table 1. Selected laboratory values.
POD – post-operative day.
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hypo-attenuating masses with peripheral nodular enhancement 
throughout the liver, suggestive of hemangiomas (Figure 1). 
The largest was located in the left hepatic lobe and measured 
26.0×18.0×27.0 cm, with 2 other hemangiomas in the right lobe 
measuring 7.0×6.0 and 3.0×3.0 cm. The centers of these mass-
es contained some hypodense areas, consistent with possible 
necrosis. There were no specific areas of biliary ductal dilation.
MRI of the abdomen (Figure 2) confirmed the presence of mul-
tiple masses in the liver with low T1 and high T2 attenuation, 
consistent with a diagnosis of massive hepatic hemangioma ex-
tending into the pelvis. Due to the patient’s advanced age, mul-
tiple medical co-morbidities, coagulopathy, and massive size of 
the tumor, hospice care at an outside hospital had been suggest-
ed. A transplant surgery opinion was sought by the consulting 
hepatologist at our center. A lengthy discussion was held with 
the patient and her family regarding risks and possible compli-
cations of surgical intervention. The patient decided against pal-
liative care and consented to a high-risk surgical intervention.
The patient underwent hepatic angiography (Figure 3) prior to 
the planned resection. An uncomplicated partial embolization 
of the giant hemangioma via the left hepatic artery using 2 vi-
als of 500–700 micron diameter embospheres was performed. 
Two days later she was taken to the operating room. Our liv-
er transplant team, including an anesthesiologist and support 
staff, participated in this surgery. Provisions were made for 
backbench ex vivo perfusion of the liver, if required. A mas-
sive transfusion protocol was set-up and a veno-venous by-
pass team was placed on standby. Surgical exposure of the gi-
ant hemangioma was obtained via a midline incision extending 
from the xiphoid process to the pubic symphysis with trans-
verse extension to the right just above the level of the umbi-
licus (Figure 4). Lysis of omental adhesions revealed compres-
sion of the right lobe of the liver and near complete atrophy of 
segments II and III. The tumor was gently rotated to the right 
and an umbilical tape was used to encircle the hepatic hilum 
in case a Pringle maneuver was necessary.
Figure 1.  Computed tomography of the abdomen with large left 
lobe mass with compression of the right lobe.
Figure 3.  Pre-operative hepatic angiography. The left hepatic 
artery feeding the massive hemagioma was embolized 
successfully to achieve reduction in tumor size.
Figure 2.  Magnetic resonance imaging of the abdomen showing 
the cranio-caudal extent of the massive cavernous 
hemangioma.
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A Cavitron Ultrasonic Surgical Aspirator (CUSA, Valleylab, USA) 
was used to divide a thin rim of segment IV, which was bridg-
ing across the anterior aspect of the tumor. This allowed ac-
cess to an avascular plane between the compressed right 
lobe and the hemangioma. Monopolar coagulation and CUSA 
were then used to for enucleation of the hemangioma with-
out any significant blood loss. The left hepatic vein was isolat-
ed. Ligation of the left hepatic artery, hepatic duct, and portal 
vein allowed mobilization of the posterior aspect of the hem-
angioma. The left hepatic vein and a thin rim of segments II 
and III were divided using a 2.5-mm endostapler (Autosuture™ 
GIA™ UNIVERSAL stapler, Norwalk, CT, USA). The specimen was 
sent for histopathological examination. The patient was ex-
tubated after 24 h, had an uneventful recovery, and was dis-
charged home on post-operative day 7.
Estimated blood loss during surgery was approximately 900 mL. 
The patient received 1 unit of packed red cells, 1 dose of plate-
lets, 2 doses of fresh frozen plasma, and 350 mL of autologous 
blood transfusion (Cell Saver® Elite®, Hemonetics, USA). The spec-
imen weighed 5.5 kg, with approximate size of 30 cm by 20 cm 
(Figure 5). The histopathological examination confirmed a num-
ber of cavernous hemangiomas with infarction and degenerative 
changes, with a pattern of bilirubinostasis in the resected liver.
Liver enzymes and hyperbilirubinemia completely normalized 
by approximately 4 months after surgery (Table 1). A follow-up 
abdominal MRI performed 2 years after the surgery revealed 
small, stable hemangiomas (the largest measuring 6.0 cm in 
diameter) in the residual right lobe of the liver. The patient 
continues to do well and is asymptomatic nearly 3 years af-
ter her surgery.
Discussion
We present a case of a massive cavernous hepatic hemangio-
ma causing compression and impending liver failure in a sep-
tuagenarian female that was successfully managed using a 
combination of enucleation and hepatic parenchymal resec-
tion after pre-operative embolization. This case highlights the 
fact that size of hemangioma and patient age should not au-
tomatically exclude them from consideration for surgical man-
agement. Timely referral of patients to a center with liver re-
section/transplantation capabilities could prove life-saving.
Hepatic hemangiomas are common, typically benign, lesions aris-
ing from the mesenchymal tissues of the liver [1]. Lesions are typ-
ically categorized by size, with the distinction of “giant” being re-
served for those greater than 4 cm in diameter [1]. Histologically, 
they are characterized by cavernous, blood-filled sinuses, which 
are lined by vascular endothelium. They are typically considered 
to be congenital rather than a neoplastic processes, with poorly 
understood biology in regards to growth patterns and factors. 
Estimates of incidence in the general population range from 0.6 
to 7% [2], and occur predominantly in the female population 
(3:1) [1]. There is a known association between lesion size and 
estrogen/progesterone levels, with lesion growth observed dur-
ing pregnancy and in conjunction with the use of oral contra-
ceptives and hormone replacement therapies [1].
Figure 4.  Gross view of the massive hemangioma involving 
the entire left lobe. The operator’s gloved fingers are 
resting over the patient’s supra-pubic area. The thin, 
compressed right lobe is barely visible.
Figure 5.  Specimen on the back table showing the massive 
cavernous hemangioma weighing 12.14 pounds 
(5.5 kg). The maximum dimension of the tumor was 
30 cm.
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Hepatic hemangiomas are typically managed expectantly be-
cause they carry a very low risk for complications such as pro-
gression to malignant disease or rupture [1]. The indications 
for operative management include pain/discomfort (22.5%), 
liver or abdominal organ dysfunction related to mass effect 
(32%, typically manifested by impaired hepatic function), sus-
picion of malignancy or inability to definitively diagnose a le-
sion as a hemangioma (20%), and a syndrome of consumptive 
coagulopathy known as Kasabach-Merritt syndrome (7.5%) [1].
First described in 1940 [2], Kasabach-Merritt syndrome is a throm-
bocytopenic purpura associated with an enlarging hemangioma. 
The typical presentation is profound thrombocytopenia (often 
less than 20×109 platelets/L), accompanied by consumptive co-
agulopathy and intravascular hemolysis reminiscent of dissemi-
nated intravascular coagulation (DIC). The proposed pathogene-
sis of this DIC is related to platelet activation and clumping when 
they come in contact with the abnormal endothelium of the tu-
mor, leading to turbulent blood flow, shearing stresses, and he-
molysis. Mainstays of therapy are primarily centered around 
obliteration of the tumor and its aberrant endothelium, which 
can be achieved by a number of techniques, including excision, 
embolization, radiotherapy, corticosteroids, or simply external 
compression with obliteration of the vascular space.
In our patient the main indication for surgery was evolving liver 
failure due to mass effect caused by the enormous hemangio-
ma. Our choice of therapy and operative approach was based 
on the prior experience of a number of surgeons. Therapeutic 
options as described in the literature included ablation, enu-
cleation, partial hepatic resection, and total hepatectomy 
with liver transplant [3–6]. While most case reports suggest-
ed enucleation (if technically feasible) as superior/non-inferi-
or to hepatic resection [7–9], evidence supporting the role of 
preoperative angiography and ablation is less clear. A number 
of case reports [10,11] made attempts to use angiography as 
a primary therapy, with varying degrees of success. However, 
many reports [1,12] described the control of the hepatic ped-
icle, with periodic clamping, as a method to temporarily de-
crease tumor size in an effort to facilitate dissection and iso-
lation of vessels supplying it.
In this case, we combined the techniques of embolization and 
periodic pedicle clamping to achieve the desired result – pre-
operative angiographic left hepatic arterial embolization – to 
provide some degree of tumor size reduction (but not necro-
sis), and hepatic pedicle clamping for further reduction of tu-
mor size or rapid in-flow control should the need arise. Most 
giant hemangiomas are most safely removed by enucleation 
when a good plane can be found between the tumor and liv-
er parenchyma. With this ‘super’ giant cavernous hemangio-
ma, we employed a combination technique of partly enucle-
ating and partly resecting the liver parenchyma to achieve the 
desired outcomes with minimal blood product requirements. 
Additionally, a back table, as would be utilized during liver 
transplantation, was prepared in the event that uncontrolla-
ble hemorrhage mandated total hepatectomy with ex-vivo liver 
perfusion, tumor resection, and implantation of the right lobe.
Conclusions
Our experience with this patient serves to reinforce previous-
ly published reports suggesting the feasibility of safely resect-
ing/enucleating giant hepatic hemangiomas. While technically 
challenging, these procedures can be accomplished success-
fully provided that sufficient support structure and facilities 
are available. We recommend that patients with giant, symp-
tomatic hepatic cavernous hemangiomas are best served by 
early referral to experienced surgical centers before the on-
set of dire complications such as severe hepatic dysfunction 
or Kasabach-Merritt syndrome.
References:
 1. Giuliante F, Ardito F, Vellone M et al: Reappraisal of surgical indications and 
approach for liver hemangioma: single-center experience on 74 patients. 
Am J Surg, 2011; 201(6): 741–48
 2. Hall GW: Kasabach-Merritt syndrome: pathogenesis and management. Br 
J Haematol, 2001; 112(4): 851–62
 3. Concejero AM, Chen CL, Chen TY et al: Giant cavernous hemangioma of the 
liver with coagulopathy: adult Kasabach-Merritt syndrome. Surgery, 2009; 
145(2): 245–47
 4. Yildiz S, Kantarci M, Kizrak Y: Cadaveric liver transplantation for a giant 
mass. Gastroenterology, 2014; 146(1): e10–1
 5. Vagefi PA, Klein I, Gelb B et al: Emergent orthotopic liver transplantation 
for hemorrhage from a giant cavernous hepatic hemangioma: case report 
and review. J Gastrointest Surg, 2011; 15(1): 209–14
 6. Kumashiro Y, Kasahara M, Nomoto K et al: Living donor liver transplanta-
tion for giant hepatic hemangioma with Kasabach-Merritt syndrome with 
a posterior segment graft. Liver Transpl, 2002; 8(8): 721–24
 7. Hochwald SN, Blumgart LH: Giant hepatic hemangioma with Kasabach-
Merritt syndrome: is the appropriate treatment enucleation or liver trans-
plantation? HPB Surg, 2000; 11(6): 413–19
 8. Zhong L, Men TY, Yang GD et al: Case report: living donor liver transplan-
tation for giant hepatic hemangioma using a right lobe graft without the 
middle hepatic vein. World J Surg Oncol, 2014; 12(1): 83
 9. Fu XH, Lai EC, Yao XP et al: Enucleation of liver hemangiomas: is there a dif-
ference in surgical outcomes for centrally or peripherally located lesions? 
Am J Surg, 2009; 198(2): 184–87
 10. Seo HI, Jo HJ, Sim MS, Kim S: Right trisegmentectomy with thoracoabdom-
inal approach after transarterial embolization for giant hepatic hemangio-
ma. World J Gastroenterol, 2009; 15(27): 3437
 11. Vassiou K, Rountas H, Liakou P et al: Embolization of a giant hepatic hem-
angioma prior to urgent liver resection. Case report and review of the lit-
erature. Cardiovasc Intervent Radiol, 2007; 30(4): 800–2
 12. Baer HU, Dennison AR, Mouton W et al: Enucleation of giant hemangiomas 
of the liver. Technical and pathologic aspects of a neglected procedure. Ann 
Surg, 1992; 216(6): 673–76
567
Sharma A. et al.: 
Enucleation of giant hepatic hemangioma
© Am J Case Rep, 2015; 16: 563-567
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License
